Publications

5674 Results

Patient-reported anxiety and fatigue in women enrolled in the RxPONDER trial (SWOG S1007) by menopausal status

Authors
M Loch;J Forschmiedt;I Kang;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;P Rastogi;A Schott;S Shak;P Sharma;D Lew;J Miao;W Barlow;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky;NL Henry
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Patient-reported cognitive impairment in women participating in the RxPONDER trial (SWOG S1007) by menopausal status

Authors
I Kang;J Forschmiedt;M Loch;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;P Rastogi;A Schott;S Shak;P Sharma;D Lew;J Miao;W Barlow;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky;NL Henry
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Baseline Insurance and Unplanned Emergency Room Use and Hospitalizations Among Elderly Breast Cancer Patients Participating in SWOG Clinical Trials

Authors
D Hershman;R Vaidya;C Till;W Barlow;M LeBlanc;JM Unger
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), PD6-04, Spotlight Poster Discussion presentation
Year
2022
Research Committee(s)
Multiple sites

Computerized Measurements of Nuclear Morphology Features, Mitosis Rate, and Tubule Formation from H&E Images Predicts Disease-Free Survival in Patients with HR+ & LN+ Invasive Breast Cancer from SWOG S8814

Authors
Y Chen;W Barlow;C Lu;A Janowczyk;G Corredor;S Ganesan;M Feldman;P Fu;H Gilmore;K Albain;L Pusztai;J Rae;D Hayes;A Godwin;A Thompson;A Madabhushi
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX, poster
Year
2022
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

SWOG 1904: Cluster-randomized controlled trial of patient and provider decision support to increase chemoprevention informed choice among women with atypical hyperplasia or lobular carcinoma in situ (MiCHOICE)

Authors
K Crew;G Anderson;K Arnold;A Stieb;J Amenta;C Law;A Sandoval-Leon;S Colonna;T King;D Mangino;S Pruthi;M Grosse-Perdekamp;C Braun-Inglis;S Krisher;L Lee;D Bertoni;S Seaward;T Ballinger;K Wisinski;J Floyd;C Zarwan;L VanderWalde;M Ross;P Steen;S Lo;A Conlin;K Yost;J Ellerton;E Lin;H Pederson;S Sardesai;S Sardesai;C Jernigan;D Hershman;M Neuhouser;B Arun;Rita Kukafka
Journal / Conference
San Antonio Breast Cancer Symposium (December 6-10, 2022, San Antonio, TX), poster, trials in progress
Year
2022
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S1904

Incidence of Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)

Authors
M Trivedi;J Unger;D Hershman;A Darke;D Hertz;T Brannagan;S Smith;B Schneider;W Irvin;A Hathaway;A Vander Woude;V Gudena;NL Henry;M Fisch
Journal / Conference
Cancer Research Vol 83, Issue 5_Suppl 1 March 2023; San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX, Spotlight Poster Discussion
Year
2022
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1714

Race and Clinical Outcomes in the RxPONDER Trial (SWOG S1007)

Authors
Y Abdou;W Barlow;J Gralow;F Meric-Bernstam;K Albain;D Hayes;N Lin;E Perez;L Goldstein;S Chia;S Dhesy-Thind;P Rastogi;E Alba;S Delaloge;A Schott;S Shak;P Sharma;D Lew;J Miao;D Tripathy;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX), oral
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

Impact of HER2 low status on clinical outcomes in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): results from SWOG S1007 (RxPONDER)

Authors
L Spring;W Barlow;A Bardia;P Sharma;L Pusztai;G Hortobagyi;K Kalinsky
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2022, San Antonio, TX), poster
Year
2022
Research Committee(s)
Breast
Study Number(s)
S1007

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Disease

Authors
S Patel;M Othus;YK Chae;M Dennis;S Gordon;B Tan;W Samlowski;E Sharon;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
Society for Immunotherapy of Cancer (SITC) (Nov 8-12,2022, Boston, MA), poster
Year
2022
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Development of a Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma

Authors
D Luan;Z Chen;L Jakobsen;M Maurer;T El-Galaly;L Nastoupil;J Cerhan;C Flowers;B Link;I Lossos;D Stephens;T Habermann;G Nowakowski;N Bartlett;J Friedberg;B Kahl;J Leonard;K Smedby;M Jerkeman;P Martin
Journal / Conference
ASH Annual Meeting (Dec 10 thru 13, 2022, New Orleans, LA), oral
Year
2022
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1412, E4494, S1001